Spots Global Cancer Trial Database for ptc299
Every month we try and update this database with for ptc299 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
PTC299 for Treatment of Advanced Cancer | NCT00704821 | Advanced Cancer | PTC299 Docetaxel | 18 Years - | PTC Therapeutics | |
PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer | NCT00508586 | Metastatic Brea... | PTC299 | 18 Years - | PTC Therapeutics | |
PTC299 for Treatment of Neurofibromatosis Type 2 | NCT00911248 | Neurofibromatos... | PTC299 | 18 Years - | PTC Therapeutics | |
PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer | NCT00508586 | Metastatic Brea... | PTC299 | 18 Years - | PTC Therapeutics | |
PTC299 for Treatment of Neurofibromatosis Type 2 | NCT00911248 | Neurofibromatos... | PTC299 | 18 Years - | PTC Therapeutics |